Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma

M Shimada, K Takenaka, K Taguchi, Y Fujiwara, T Gion, K Kajiyama, T Maeda, K Shirabe, K Yanaga, K Sugimachi, M Shimada, K Takenaka, K Taguchi, Y Fujiwara, T Gion, K Kajiyama, T Maeda, K Shirabe, K Yanaga, K Sugimachi

Abstract

Objective: The aims of this study were to identify prognostic factors in patients who developed recurrent hepatocellular carcinoma (HCC) after repeat hepatectomy and to elucidate the role of multicentric occurrence in the second tumor after a first hepatectomy.

Summary background data: A repeat hepatectomy for recurrent HCC has been established as the most effective treatment modality, whenever it is possible. However, the prognostic factors for recurrent HCC after repeat hepatectomy have yet to be clarified.

Methods: Forty-one patients who underwent a curative repeat hepatectomy were retrospectively studied. Patient survival and disease-free survival after recurrence were univariately and multivariately analyzed using 38 clinicopathologic variables. The histologic grade of HCC at repeat hepatectomy was also compared with that at first hepatectomy.

Results: Patient survival after repeat hepatectomy did not differ substantially from that in 312 patients undergoing primary hepatectomy. However, the disease-free survival after repeat hepatectomy was significantly lower than that in patients with only a primary hepatectomy (p < 0.05). Multivariate analysis revealed only portal vein invasion in the first hepatectomy to be an independent and significantly poor prognostic factor. Regarding multicentric occurrence at repeat hepatectomy, only 6 of 40 patients (15%) whose specimens could be evaluated histologically were determined to be Edmondson and Steiner's Grade 1.

Conclusions: The only prognostic factor identified in patients with recurrent HCC after repeat hepatectomy was portal vein invasion in the first hepatectomy. Most second tumors after the first hepatectomy are considered to be caused by metastatic recurrence, not by multicentric occurrence.

References

    1. Cancer. 1987 Aug 15;60(4):810-9
    1. Br J Surg. 1996 Jan;83(1):127-31
    1. Hepatology. 1989 Mar;9(3):457-60
    1. Hepatology. 1989 Jul;10(1):98-102
    1. Am J Surg Pathol. 1989 Dec;13(12):1064-7
    1. Surg Gynecol Obstet. 1990 Nov;171(5):398-402
    1. Hum Pathol. 1991 Feb;22(2):125-30
    1. Hum Pathol. 1991 Feb;22(2):172-8
    1. Biometrics. 1973 Sep;29(3):579-84
    1. N Engl J Med. 1984 May 31;310(22):1427-31
    1. Hepatology. 1991 May;13(5):923-8
    1. Hepatology. 1991 Nov;14(5):802-5
    1. Cancer Res. 1992 Mar 15;52(6):1504-9
    1. Ann Surg. 1993 Jan;217(1):28-34
    1. Gastroenterology. 1993 Aug;105(2):488-94
    1. Am J Surg. 1993 Sep;166(3):270-3
    1. Gastroenterology. 1994 Mar;106(3):720-7
    1. Hepatology. 1994 Apr;19(4):889-94
    1. Surgery. 1994 Apr;115(4):452-7
    1. J Surg Oncol. 1994 May;56(1):54-8
    1. Gastroenterology. 1994 Jun;106(6):1618-24
    1. Surgery. 1994 Jun;115(6):703-6
    1. Arch Surg. 1994 Jul;129(7):738-42
    1. Am J Surg. 1995 Apr;169(4):400-4; discussion 405
    1. Cancer. 1996 Mar 15;77(6):1050-5
    1. Gastroenterology. 1996 Sep;111(3):720-6
    1. Cancer. 1954 May;7(3):462-503
    1. Gastroenterology. 1988 Dec;95(6):1664-6

Source: PubMed

3
Prenumerera